Company news
Me Therapeutics Holdings, Inc. (CSE:METX) news
Me Therapeutics Holdings, Inc. news releases on 6ix. Latest, Sep 8, 2026: ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA STING Programs
Press releases & updates
ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA STING Programs
September 8, 2026
ME Therapeutics Closes Over-Subscribed Private Placement
July 17, 2026
ME Therapeutics Announces Private Placement
June 3, 2026
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver
May 7, 2026
ME Therapeutics Provides Scientific Update on In Vivo CAR and Therapeutic mRNA Programs
April 29, 2026
ME Therapeutics Scientific and Corporate Update
January 30, 2026
ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program
October 16, 2025
ME Therapeutics Added to CSE25 Index
October 10, 2025
ME Therapeutics Secures U.S. Patent for Lead Candidate and Advances Broader Therapeutic Programs
September 26, 2025
ME Therapeutics Receives Support to Advance mRNA Therapeutic Candidates for Cancer and Inflammatory Disease
May 21, 2025
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in Vivo
January 14, 2025
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
ME Therapeutics Holdings Inc. Provides Research and Development Update and Corporate Update
October 22, 2024
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
September 18, 2024
ME Therapeutics Announces New Collaboration with NanoVation Therapeutics on Advanced Therapeutic mRNA Delivery to Myeloid Cells
July 8, 2024
ME Therapeutics Holdings Inc. Announces the Addition of Two New Clinical Consultants to Continue the Advancement of Our Lead Anti-G-CSF Antibody Candidate Towards a First-in-Human Clinical Trial
May 29, 2024
ME Therapeutics Holdings Inc. Announces Ringing of CSE Opening Bell on April 17, 2024
April 15, 2024
ME Therapeutics Holdings Inc. Announces Upcoming Participation in the 2024 Bloom Burton & Co Health Care Conference and Interview On CSE TV
March 26, 2024
ME Therapeutics Announces Closing of Non-Brokered Private Placement
March 6, 2024
ME Therapeutics Announces Non-Brokered Private Placement and Provides Corporate Update
February 27, 2024